Larvol Delta - RPLMRS-Rituximab-Pirtobrutinib-Lisaftoclax-and-Liposomal-Mitoxantrone-for-for-Richter-Syndrome-Transformed-From-CLL

Rituxan (rituximab) - Roche

Jaypirca (pirtobrutinib) - Eli Lilly

Duoenda (mitoxantrone liposomal) - CSPC Pharma

lisaftoclax (APG-2575) - Ascentage Pharma

http://clinicaltrials.gov/ct2/show/NCT07831395

Sep 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next